Transgene Biotek Q4 Results
- BSE: 526139
- NSE: -
- ISIN: INE773D01018
- Sector: Biotechnology & Drugs
BSE
2.70
-0.07 (-2.53%)
-0.07 (-2.53%)Volume17.42 K
Updated: Tue 15 Sep, 2026 | 15:29:17
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Transgene Biotek Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.38 | 0.15 | 148.61% | 0.33 | -40.13% |
| Depreciation/ Amortization | 0.05 | 0.05 | 0.00% | 0.02 | 111.91% |
| Operating Income | -0.33 | -0.10 | 229.44% | -0.28 | -41.67% |
| Net Income | -0.46 | -0.37 | 22.26% | -0.26 | -35.91% |
| Other Operating Expenses Total | 0.30 | 0.07 | 319.22% | 0.23 | -45.81% |
| Net Income Before Taxes | -0.46 | -0.37 | 22.26% | -0.26 | -35.91% |
| Total Revenue | 0.05 | 0.05 | 0.00% | 0.05 | -28.76% |
| Selling/ General/ Admin Expenses Total | 0.03 | 0.03 | 2.11% | 0.08 | -46.69% |
| Diluted Normalized EPS | -0.06 | -0.05 | 20.00% | -0.04 | -36.24% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.